GENEVA: The GAVI alliance announced on Monday that it had signed two advance purchase agreements with Chinese pharmaceutical companies Sinopharm and Sinovac to supply the COVAX programme with up to 550 million COVID-19 vaccines.
The deals include up to 170 million doses of the Sinopharm vaccine and up to 380 million doses of the Sinovac vaccine, through to the middle of 2022, the statement said. Sinovac confirmed the agreement in a statement.
“The agreements, which come at a time when the Delta variant is posing a rising risk to health systems, will begin to make 110 million doses immediately available to participants of the COVAX Facility, with options for additional doses,” GAVI said in a statement.
Due to Indian export disruptions, COVAX, which distributes vaccines to poorer countries, has struggled to meet its early commitments, forcing many countries to halt their inoculation programmes in their early stages.
However, the programme is on track to deliver more than 2 billion doses by early 2022, according to the most recent supply forecast.
A high-level Syrian delegation led by the Deputy Minister of Education of Syria Mr. Rami…
Jalal Khan, a progressive farmer, who achieved bumper wheat crop this season seemed upset after…
Chairman of the of the Prime Minister's Youth Programme, Rana Mashhood Ahmed Khan, has reiterated…
The National Disaster Management Authority (NDMA), in collaboration with United Nations Economic and Social Commission…
The Sindh Chief Minister Syed Murad Ali Shah has said that his government is committed…
The independent candidate aspiring to contest the by-election in PP-269 has announced to stand down…
Leave a Comment